Related Experiment Videos
Aberrant TGF-beta production and regulation in metastatic malignancy
L C Schwarz1, J A Wright, M C Gingras
1Manitoba Institute of Cell Biology, Winnipeg, Canada.
Abstract:
We have examined the possible role of transforming growth factor-beta (TGF-beta) in metastatic malignancy by analyzing the production and activation of TGF-beta 1 and -beta 2 and the regulation of TGF-beta-responsive genes in oncogene-transformed metastatic fibrosarcomas. All transformed lines derived from either 10T1/2 or NIH 3T3 by either H-ras or protein-kinase encoding oncogenes produced more TGF-beta than parental cells. However, only highly metastatic fibrosarcomas secreted activated TGF-beta at rates that were greater than parental fibroblasts. Immunohistochemical staining for TGF-beta 1 showed widespread intra- and extracellular distribution in metastatic lung nodules and adjacent tissue. Cells isolated from tumors successfully metastasizing to the lung had TGF-beta 1 mRNA levels which were increased 19-fold over in vitro controls. Despite the greatly enhanced rate of secretion of activated TGF-beta, metastatic cells exhibited markedly altered responses of TGF-beta 1 and TGF-beta 2, being unable to either increase collagen secretion or enhance collagen alpha 2(1) or TGF-beta 1 mRNA levels. This lack of response was not due to either altered TGF-beta receptor affinity or numbers. Metastatic progression was, therefore, associated with an increase in the secretion of activated TGF-beta 1 and a loss of the ability to deregulate TGF-beta-responsive genes.
Insights
Metastatic fibrosarcomas increase secretion of activated transforming growth factor-beta 1 (TGF-beta 1) but lose responsiveness to TGF-beta signaling, impacting gene regulation during cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metastasis Research
Background:
- Transforming growth factor-beta (TGF-beta) plays a complex role in cancer, influencing cell growth, differentiation, and immune evasion.
- Understanding TGF-beta's function in metastatic malignancy is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the production, activation, and signaling of TGF-beta 1 and TGF-beta 2 in oncogene-transformed metastatic fibrosarcomas.
- To analyze the regulation of TGF-beta-responsive genes in the context of metastatic progression.
Main Methods:
- Analysis of TGF-beta 1 and -beta 2 production and activation in fibrosarcoma cell lines.
- Assessment of TGF-beta-responsive gene regulation (e.g., collagen secretion, mRNA levels).
- Immunohistochemical staining and mRNA level analysis of TGF-beta 1 in metastatic lung nodules.
Main Results:
- Oncogene-transformed fibrosarcomas showed increased TGF-beta production compared to parental cells.
- Highly metastatic fibrosarcomas exhibited enhanced secretion of activated TGF-beta 1.
- Metastatic cells displayed a diminished ability to respond to TGF-beta, indicated by unchanged collagen secretion and TGF-beta 1 mRNA levels despite increased TGF-beta secretion.
- TGF-beta receptor affinity and numbers remained unaltered in metastatic cells.
Conclusions:
- Metastatic progression in fibrosarcomas is associated with increased secretion of activated TGF-beta 1.
- Metastatic cells develop resistance to TGF-beta signaling, losing the capacity to deregulate TGF-beta-responsive genes.
- This dissociation between TGF-beta secretion and response may contribute to uncontrolled tumor growth and spread.